-
It is a well-known fact that as we get older, our bones lose mass and become increasingly weaker.
-
FDA asked Bayer Pharmaceuticals Corp. to suspend marketing of Trasylol®, used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study suggesting an increased risk for death.
-
Spurred by a medication error involving dangerous doses of heparin administered to the newborn children of actor Dennis Quaid, the American Society of Health-System Pharmacists (ASHP) reiterated calls for systemic changes to help reduce medication errors.
-
Using a multidisciplinary medication reconciliation process can reduce the number of medication discrepancies that occur during admission and discharge.
-
Research conducted by Temple University Hospital and Temple University School of Pharmacy has found that having a pharmacist make rounds with a medicine team improves the accuracy of medication reconciliation and decreases adverse events due to medication error.
-
-
Many nursing home patients are admitted with prescriptions for proton pump inhibitors or H2-receptor antagonists without any obvious indication.
-
Incidentalomas:It's All In Your Head, Skin Cancer Screening: Our Patients Want It!, and Bell's Palsy: Steroids, Acyclovir, Both, or Neither?
-
Sorafenib has been approved by the FDA forthe treatment of inoperable hepatocellular cancer. It is an oral multikinase inhibitor that was previously approved for advanced renal cell carcinoma. It is manufactured by Bayer HealthCare AG in Germany and marketed by Bayer Pharmaceuticals Corporation as Nexavar.
-
Although pancreatic cancer growth is considered rapid, early recognition of resectable disease remains the best chance for long-term survival. It is possible that an early sign of evolving pancreatic neoplasm is glucose intolerance. In a series of 30 pancreatic cancer patients evaluated at the Mayo Clinic, CT scans obtained 6 months or more before the diagnosis revealed potentially resectable lesions in some, and this was notably true for those who had CT scans and new-onset diabetes several months before the diagnosis of pancreatic cancer. Thus, physicians evaluating adults with newly diagnosed diabetes should consider the possibility that the glucose intolerance is an accompaniment of early pancreatic neoplasia.
